Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Chelsea M. Peterson"'
Autor:
Jason M. Zimmerer, Jing L. Han, Chelsea M. Peterson, Qiang Zeng, Bryce A. Ringwald, Clarissa Cassol, Sachi Chaudhari, Madison Hart, Jessica Hemminger, Anjali Satoskar, Mahmoud Abdel-Rasoul, Jiao-Jing Wang, Robert T. Warren, Zheng J. Zhang, Christopher K. Breuer, Ginny L. Bumgardner
Publikováno v:
Am J Transplant
CCR5 KO kidney transplant (KTx) recipients are extraordinarily high alloantibody producers and develop pathology that mimics human antibody-mediated rejection (AMR). C57BL/6 and CCR5 KO mice (H-2(b)) were transplanted with A/J kidneys (H-2(a)); selec
Autor:
Jing Han, Madison M Hart, Ginny L. Bumgardner, Robert T. Warren, Chelsea M Peterson, Bryce A Ringwald, Sachi R Chaudhari, Mahmoud Abdel-Rasoul, Jason M. Zimmerer
Publikováno v:
J Immunol
Hepatocyte transplant represents a treatment for metabolic disorders but is limited by immunogenicity. Our prior work identified the critical role of CD8+ T cells, with or without CD4+ T cell help, in mediating hepatocyte rejection. In this study, we
Autor:
Chelsea M. Peterson, Tin-Shuan Uen, Luis Rodriguez, Stanley G. Solomon, Ana Paula Spranger Correia de Oliveira, Richard Sowers
Publikováno v:
SSRN Electronic Journal.
Publikováno v:
2020 ASABE Annual International Virtual Meeting, July 13-15, 2020.
Publikováno v:
2020 ASABE Annual International Virtual Meeting, July 13-15, 2020.
Autor:
Jason M Zimmerer, Jing Han, Madison Hart, Sachi Chaudhari, Chelsea M Peterson, Ginny L Bumgardner
Publikováno v:
The Journal of Immunology. 206:28.17-28.17
The novel CXCR5+CD8+ T cell subset has been shown to inhibit alloantibody production (termed CD8+ TAb-supp cells) but do not reject allografts. In contrast, CXCR3+CD8+ T cells reject allogeneic transplants (but do not inhibit antibody). Recent litera
Autor:
Bryce Alan Ringwald, Jason M Zimmerer, Sachi Chaudhari, Jing Han, Chelsea M Peterson, Robert T Warren, Madison Hart, Mahmoud Abdel-Rasoul, Ginny L Bumgardner
Publikováno v:
The Journal of Immunology. 206:28.11-28.11
Hepatocyte transplant (HcTx) is a treatment for metabolic diseases and a bridge to liver transplant but is limited by immunogenicity. Our prior work identified the critical role of CD4-dependent and CD4-independent CD8+ T cells in HcTx rejection. Her